(Q55067922)

16 June 2018

review article

1 reference

title

Design of selective inhibitors of cyclooxygenase-2 as nonulcerogenic anti-inflammatory agents. (English)

1 reference

16 June 2018

author name string

Marnett LJ

series ordinal

1

1 reference

16 June 2018

Kalgutkar AS

series ordinal

2

1 reference

16 June 2018

publication date

1 August 1998

1 reference

16 June 2018

Current Opinion in Chemical Biology

published in

1 reference

16 June 2018

volume

2

1 reference

16 June 2018

page(s)

482-490

1 reference

16 June 2018

issue

4

1 reference

16 June 2018

Photolabeling of Prostaglandin Endoperoxide H Synthase-1 with 3-Trifluoro-3-(m-Iiodophenyl)diazirine as a Probe of Membrane Association and the Cyclooxygenase Active Site

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980124-5

7 January 2021

Prostaglandin synthase 2.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980124-5

7 January 2021

PGH synthase isoenzyme selectivity: the potential for safer nonsteroidal antiinflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980124-5

7 January 2021

Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980124-5

7 January 2021

The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980124-5

7 January 2021

Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980124-5

7 January 2021

Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980124-5

7 January 2021

Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980124-5

7 January 2021

Human cyclooxygenase-2 cDNA

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980124-5

7 January 2021

Structural requirements for time-dependent inhibition of prostaglandin biosynthesis by anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980124-5

7 January 2021

Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980124-5

7 January 2021

The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980124-5

7 January 2021

Synthesis and use of iodinated nonsteroidal antiinflammatory drug analogs as crystallographic probes of the prostaglandin H2 synthase cyclooxygenase active site

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980124-5

7 January 2021

Involvement of arginine 120, glutamate 524, and tyrosine 355 in the binding of arachidonate and 2-phenylpropionic acid inhibitors to the cyclooxygenase active site of ovine prostaglandin endoperoxide H synthase-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980124-5

7 January 2021

Arginine 120 of prostaglandin G/H synthase-1 is required for the inhibition by nonsteroidal anti-inflammatory drugs containing a carboxylic acid moiety

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980124-5

7 January 2021

Higher oxidation states of prostaglandin H synthase. EPR study of a transient tyrosyl radical in the enzyme during the peroxidase reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980124-5

7 January 2021

Structural characterization of arachidonyl radicals formed by prostaglandin H synthase-2 and prostaglandin H synthase-1 reconstituted with mangano protoporphyrin IX

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980124-5

7 January 2021

Nitric oxide trapping of tyrosyl radicals generated during prostaglandin endoperoxide synthase turnover. Detection of the radical derivative of tyrosine 385

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980124-5

7 January 2021

NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980124-5

7 January 2021

Studies on antiinflammatory agents. II. Synthesis and pharmacological properties of 2'-(phenylthio)methanesulfonanilides and related derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980124-5

7 January 2021

Novel terphenyls as selective cyclooxygenase-2 inhibitors and orally active anti-inflammatory agents

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980124-5

7 January 2021

Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib).

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980124-5

7 January 2021

Studies on anti-inflammatory agents. IV. Synthesis and pharmacological properties of 1,5-diarylpyrazoles and related derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980124-5

7 January 2021

Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980124-5

7 January 2021

Diarylspiro[2.4]heptenes as orally active, highly selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationships

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980124-5

7 January 2021

1,2-Diarylimidazoles as potent, cyclooxygenase-2 selective, and orally active antiinflammatory agents

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980124-5

7 January 2021

1,2-Diarylpyrroles as potent and selective inhibitors of cyclooxygenase-2

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980124-5

7 January 2021

A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980124-5

7 January 2021

Conversion of prostaglandin G/H synthase-1 into an enzyme sensitive to PGHS-2-selective inhibitors by a double His513 --> Arg and Ile523 --> val mutation

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980124-5

7 January 2021

Role of Val509 in time-dependent inhibition of human prostaglandin H synthase-2 cyclooxygenase activity by isoform-selective agents

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980124-5

7 January 2021

2,6-di-tert-butylphenols: a new class of potent and selective PGHS-2 inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980124-5

7 January 2021

Effect of structural modification of enol-carboxamide-type nonsteroidal antiinflammatory drugs on COX-2/COX-1 selectivity

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980124-5

7 January 2021

Evaluation of pharmacological profile of meloxicam as an anti-inflammatory agent, with particular reference to its relative selectivity for cyclooxygenase-2 over cyclooxygenase-1

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980124-5

7 January 2021

Meloxicam: influence on arachidonic acid metabolism. Part 1. In vitro findings

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980124-5

7 January 2021

Meloxicam: influence on arachidonic acid metabolism. Part II. In vivo findings

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980124-5

7 January 2021

Acetylation of prostaglandin synthase by aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980124-5

7 January 2021

Topographic studies of microsomal and pure prostaglandin H synthase

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980124-5

7 January 2021

Kinetics of the interaction of nonsteroidal antiinflammatory drugs with prostaglandin endoperoxide synthase-1 studied by limited proteolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980124-5

7 January 2021

Protection of prostaglandin H synthase from trypsin upon binding of heme

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980124-5

7 January 2021

Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980124-5

7 January 2021

Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980124-5

7 January 2021

Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980124-5

7 January 2021

Altered pain perception and inflammatory response in mice lacking prostacyclin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980124-5

7 January 2021

Failure of parturition in mice lacking the prostaglandin F receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980124-5

7 January 2021

Aspirin-like molecules that covalently inactivate cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2898%2980124-5

7 January 2021

10.1016/S1367-5931(98)80124-5

Identifiers

DOI

1 reference

16 June 2018

PubMed ID

9736921

1 reference

16 June 2018